OHOlivia Hernández-González

Olivia Hernández-González

*This is an algorithmically generated author record based on publicly available information.

Olivia Hernández-González has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Alberto Hidalgo-Bravo

    Departamento de Medicina Genómica, Instituto Nacional de Rehabilitación (INR), Mexico City 14389, Mexico

    1 shared publication
  • Alexandra Luna-Angulo

    Neuromuscular Diseases Laboratory, Clinical Neurosciences Division, National Institute of Rehabilitation “Luis Guillermo Ibarra Ibarra”, Mexico City 14389, Mexico

    1 shared publication
  • Beatriz del Carmen Couder-García

    SECIHTI-Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, Subsede Sureste, Parque Científico Tecnológico de Yucatán, Tablaje Catastral 31264, Mérida 97302, México.

    1 shared publication
  • Brandon Eduardo Galicia-Canales

    Cellular Therapy and Regenerative Medicine Tissue Engineering Unit, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico.

    1 shared publication
  • Carlos Landa-Solís

    Tissue Engineering, Cell Therapy and Regenerative Medicine Unit, National Institute of Rehabilitation “Luis Guillermo Ibarra Ibarra”, Mexico City 14389, Mexico

    1 shared publication
  • Dalia Lizbeth Monroy-Quiroz

    Cellular Therapy and Regenerative Medicine Tissue Engineering Unit, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico.

    1 shared publication

Latest Publications

  • Open Access

    Molecular evaluation of quercetin effects in a murine model of giant cell tumor of bone: an in vivo pilot study

    by Dalia Lizbeth Monroy-Quiroz, Alexandra Berenice Luna-Angulo, Brandon Eduardo Galicia-Canales, Laura Sánchez-Chapul, Olivia Hernández-González, María del Rocío Aguilar-Gaytán, Mónica Guadalupe Santamaría-Olmedo, Alberto Hidalgo-Bravo, Beatriz del Carmen Couder-García, Gabriel Lara-Hernández, et al.

    Quercetin, a flavonoid derived from plant sources, has been extensively studied for its numerous biological properties, particularly its potential antitumor action against various malignant neoplasms. In our experience with a giant cell tumor of bone cell line (TIB-223), we demonstrated that quercetin has the ability to induce apoptosis via caspase-3. Therefore, this study aimed to evaluate molecular markers for apoptosis, necrosis, and cell proliferation in a murine model of giant cell tumor of bone, to determine whether the behavior reported for quercetin in 2D remains consistent in a 3D in vivo tumor model. Tumor constructs based on TIB-223 cells were implanted into athymic mice, and two weeks post-implantation, the mice were orally administered quercetin at a concentration of 100 mg/kg body weight once a day for two weeks. The control group received only 200 µL of the vehicle. Our results demonstrate the activation of two cell death pathways in the implanted tumors: apoptosis, via Caspase-8 to Caspase-3 activation, and necroptosis, via RIPK1. No significant effect on cell proliferation was observed, as PCNA expression remained unchanged. Our results suggest that quercetin may induce specific mechanisms of cell death without significantly altering cell proliferation in the tumor model induced in mice.